Robbins Headache Clinic Blog
Acute Risk of Migraine Linked to White Light Exposure
The level of exposure to white light is associated with acute risk of headache onset in patients with episodic migraine, according to research presented at the annual meeting of the American Headache Society. The data raise the question of whether modifying light...
New Daily Persistent Headache: A Systemic Review on an Engimatic Disorder
New daily persistent headache (NDPH) presents with a sudden onset headache which continues without remission within 24?h. Although rare, NDPH is important because it is one of the most treatment refractory primary headache disorders and can be highly disabling to the...
New Drug Relieves Acute Migraine in Clinical Trial
People who experience acute migraine may soon find relief in a new treatment. The results of a clinical trial of a novel drug revealed that it can eliminate head pain and reduce other symptoms of migraine. Read more here.
Why Newer Migraine Blockers Fail Some Patients
Research in an animal model of headache suggests that different underlying mechanisms at work in migraine may explain why some calcitonin gene-related peptide inhibitors, such as fremanezumab, may not work for everyone. Read more here.
High School Start Time and Migraine
In this cross-sectional observational study with 256 students, researchers explored whether a later high school start time was correlated with lower migraine frequency in high school students with migraine. Using social media, participants were recruited nationally....
CGRP AND SIDE EFFECTS: LETTER IN ‘HEADACHE”
This is a new letter to the editor that I wrote, in the journal Headache; these newer CGRP meds are marvelous for many patients, but the true side effect profile is just evolving: (LETTER FROM THE JOURNAL HEADACHE, JULY, 2019: LAWRENCE ROBBINS,M.D.) Erenumab, the...
The Role of Antiepileptic Drugs for Prevention of Migraine
Antiepileptic drugs (AEDs) are frequently used as a preventive treatment for the management of migraine. Topiramate (TPM) and valproic acid (VPA) are 2 AEDs that have demonstrated efficacy in reducing the frequency of migraine attacks. Read more here.
Navigating Effective Approaches to Migraine Therapy for the Underinsured
Despite the availability of new therapies, the vast majority of people with migraine headache receive inadequate treatment. A 2013 study by Lipton et al1proposed 3 steps to achieving minimally effective pharmacologic therapy for acute and chronic migraine. Read more...
Light: A Therapy (and Trigger) for Migraines
While some light can worsen episodes, green light may ease them Read more here.
Prevention Strategies for Pediatric Migraine
Migraine in children and adolescents remains underrecognized and underdiagnosed due to challenges like nonspecific symptoms, poor articulation of symptoms from patients, and lack of awareness of the prevalence of migraine in these populations. Read more here.